來源:[1] Recursion Pharmaceuticals, Inc. (RXRX) 隨著 REV102 取得進展,獲得 Rallybio 1250 萬美元里程碑付款 (https://finance.yahoo.com/news/recursion-phar ...)[2] Recursion Pharmaceuticals 從 Rallybio 收購 ENPP1 抑制劑項目的全部權益 | RXRX 股票新聞 - GuruFocus (https://vertexaisearch.cloud.google.com/groun ...)[3] RXRX 股價飆升:接下來會怎樣? (https://vertexaisearch.cloud.google.com/groun ...)